Enhancing the Secondary Prevention of Coronary Artery Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

480

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

August 31, 2011

Study Completion Date

July 31, 2015

Conditions
Coronary DiseaseIschemic Heart Disease
Interventions
BEHAVIORAL

Evidence summaries endorsed by local opinion leaders

Trial Locations (1)

T6G 2B7

University of Alberta Hospital; Royal Alexandra Hospital, Foothills Medical Centre (Calgary), Edmonton

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Heart and Stroke Foundation of Canada

OTHER

collaborator

Alberta Heritage Foundation for Medical Research

OTHER

collaborator

Pfizer

INDUSTRY

lead

University of Alberta

OTHER